Top in GI: Practice update on deprescribing PPIs, COVID-19 vaccine in patients with IBD
Click Here to Manage Email Alerts
As proton pump inhibitors are being increasingly used for “less clear indications and indeterminate durations,” the American Gastroenterological Association announced a clinical practice update on deprescribing the agents in certain patients.
According to the organization, all patients receiving PPIs should undergo regular review for their ongoing indication for use, and physicians should consider deprescribing in those without a definitive indication. In addition, the AGA stated that most patients on twice-daily PPI dosing may be decreased to once-daily dosing.
A review of the clinical practice update was the top story in gastroenterology last week.
The second top story was about the safety and efficacy of COVID-19 vaccination in patients with inflammatory bowel disease, who were previously excluded from clinical trials evaluating the vaccines.
Read these and more top stories in gastroenterology below:
AGA clinical practice update: De-prescribing PPIs reduces costs, risks for adverse events
The AGA has issued a clinical practice update on deprescribing PPIs, according to an article in Gastroenterology. Read more.
SARS-CoV-2 vaccine produces strong antibody response in IBD patients
A comprehensive review of data showed that two doses of a SARS-CoV-2 vaccine were safe and effective in patients with inflammatory bowel disease, according to a report in Alimentary Pharmacology & Therapeutics. Read more.
Social media branding opens doors, helps advance career
Creating a personal brand on social media is a key component in building your reputation both professionally and personally, according to a speaker at Scrubs & Heels Summit 2022. Read more.
VIDEO: What’s in a name? How a premalignant esophageal condition bears the name Barrett
In this Endo-Sketch, a Healio video series on clinical conditions named after famous colleagues, Klaus Mergener, MD, of the University of Washington School of Medicine, discusses the origin of Barrett’s esophagus. Read more.
IBS Awareness Month: Diagnostic tips, treatment options, multidisciplinary care and more
April is IBS Awareness Month and highlights the importance of public awareness and health messages about the diagnosis, treatment and quality of life for patients with irritable bowel syndrome. Read more.